Logo

Kaneka Launches New PCR Test Kit for Identifying the COVID-19 Omicron (BA.1) and "Stealth" Omicron (BA.2) Variants

Category: Biomedical
Posted Apr 18, 2022 14:19 (GMT +7)

- Test kit capable of detecting both types of Omicron variants with a single PCR test

TOKYO--(BUSINESS WIRE)--Apr. 18, 2022

On March 31, Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) released KANEKA RT-PCR Kit “SARS-CoV-2 (Omicron/Delta) ver.2”, a real-time PCR test kit capable of simultaneously detecting the Omicron (BA.1), "Stealth" Omicron (BA.2), and Delta variants of COVID-19. The kit has a suggested retail price of 121,000 yen (for 100 tests), including tax.

This test kit uses a proprietary reagent developed using Kaneka's molecular testing-related technologies to detect the presence of three variants with a single PCR test. This is expected to help reduce the burden placed by testing and to assist with selecting the best suitable drugs and treatment approaches for each variant in clinical settings.

Kaneka has already released the KANEKA Direct RT-PCR Kit SARS-CoV-2, an in-vitro diagnostic reagent that uses Kaneka's original sample processing technology to produce test results in less than an hour, KANEKA RT-PCR Kit “SARS-CoV-2 (L452R/E484Q/E484K/N501Y)”, which can detect four variants simultaneously, and KANEKA RT-PCR Kit “SARS-CoV-2 (Omicron/Delta)” which can detect the Delta and Omicron variants of COVID-19. These Kaneka products are being used at major sporting events and for pre-travel PCR testing, as well as in medical facilities and testing centers. These products make it possible to quickly test large numbers of samples.

Kaneka is taking a wide range of measures to combat COVID-19. These include the launching of the “Infection Initiative Team,” which conducts research and development regarding infection control measures including COVID-19, expanding our lineup of PCR test kits, performing contract manufacturing of DNA vaccine APIs and intermediates, developing antibody drugs, supplying PCR testing reagents and testing kits, and shipping vaccine using temperature-controlled packages.

* Relationship between detected COVID-19 mutations and variants (+: positive, -: negative)

E484A

(characteristic of the BA.1, BA.2)

N856K

(characteristic of the BA.1)
L452R

(characteristic of the Delta)

Determination

+

+

-

==>

BA.1

+

-

-

==>

BA.2

-

-

+

==>

Delta

These refer to mutations of the amino acids in viral spike proteins. The names are based on the mutation. In the E484A mutation, the spike protein has changed from E (glutamine acid) to A (alanine). In the N856K mutation, the change was from N (asparagine) to K (lysine). In the L452R mutation, it was from L (lysine) to R (arginine).

Inquiry Form: https://www.kaneka-labtest.com/en/contact-us.html

View source version on businesswire.com: https://www.businesswire.com/news/home/20220412005637/en/

Contact:

KANEKA CORPORATION
Investors & Public Relations Department
Chika Harada
Info_PRoffice@kaneka.co.jp

Source: Kaneka Corporation

Distribute your news release with us

  • Print

    unique advertising solution

    Our media lists include news desks at all leading Thai and English-language dailies.

  • Radio & TV

    reliable platform

    We deliver your news to leading Thai radio stations and TV channels.

  • Internet Sites

    cloud computing

    All releases are submitted to Internet news sites, including several with guaranteed pickup.

Our Self-Serve News Release Couldn't Be Simpler

Our streamlined online process makes it simple and fast to submit your news to the Thai media. Once registered, just enter or copy your text into our submission form and you'll see an instant preview with our fee based on the word count, translation, and any attached image. To confirm submission, hit Enter to be taken to our payment processor. Once payment is approved, your release passes automatically to our news desk for translation and dissemination by our skilled and experienced team. You'll be kept informed at each step of the process.

Do NOT follow this link or you will be banned from the site!